Table 1 Follow-up profiles.
Follow-up profiles | n = 13,971 |
|---|---|
No vaccination, no diagnosis of SARS-CoV-2 infection (NoVac, NoDiag) | 1932 (13.8%) |
1 vaccine injection, no diagnosis of SARS-CoV-2 infection (1Vac, NoDiag) | 3463 (24.8%) |
2 or 3 vaccine injections, no diagnosis of SARS-CoV-2 infection (2or3Vac, NoDiag)a | 5069 (36.3%) |
No vaccination, diagnosis of SARS-CoV-2 infection (NoVac, 1Diag) | 1116 (8.0%) |
Infected during the first pandemic wave | 834 |
Infected during the follow-up | 282 |
No vaccination, 2 diagnoses of SARS-CoV-2 infection (NoVac, 2Diag) | 82 (0.6%) |
Infected during the first pandemic wave | 82 |
Infected during the follow-up | 82 |
1 or 2 vaccine injections before a diagnosis of SARS-CoV-2 infection (1or2Vac- > Diag)b | 37 (0.3%) |
Infected during the first pandemic wave | 4 |
Infected during the follow-up | 37 |
Diagnosis of SARS-CoV-2 infection before 1 vaccine injection (Diag- > 1Vac) | 1596 (11.4%) |
Infected during the first pandemic wave | 1350 |
Infected during the follow-up | 303 |
Diagnosis of SARS-CoV-2 infection before 2 or 3 vaccine injection (Diag- > 2or3Vac)c | 676 (4.8%) |
Infected during the first pandemic wave | 643 |
Infected during the follow-up | 39 |
